BCIQ Profiles

Company Profile Report
0402 Fin-Deal QTs
BioCentury & Getty Images


April 2 Quick Takes: Agios begins share buybacks upon closing Servier deal, plus Royalty-GSK, Gracell-Lonza, Alloy, Eloxx-Zikani and Angelini-Ovid

Apr 3, 2021 | 1:32 AM GMT

Upon completing the sale of its cancer business to Servier for $1.8 billion up front and up

Read the full 469 word article

How to gain access

Continue reading with a
two-week free trial.